Cyclic GMP and outer hair cell electromotility

Magdolna Szönyi, David Z. He, Ottó Ribári, István Sziklai, Peter Dallos

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The aim of this study is to examine the effect of phosphorylation pathways on the electrically evoked fast motile response of isolated outer hair cells (OHCs). Transcellular electrical stimulation was applied in the microchamber to guinea pig OHCs and motility was measured before and after drug application. Forskolin (adenylate cyclase activator), phorbol 12- myristate 13-acetate (PMA, protein kinase C activator) and dibutyryl 3',5'- cyclic guanosine monophosphate (cGMP agonist) were studied. As controls, L15 medium and dimethyl-sulfoxide (DMSO) were used. In each group, 12 cells were measured. Forskolin and PMA were dissolved in 0.1% DMSO to render them membrane permeable. DMSO by itself caused a statistically significant electromotility magnitude decrease. Forskolin and PMA could not reverse the motility decrease due to DMSO, the effects seen in their presence were the same as observed with DMSO alone. Thus, neither 3',5'-cyclic AMP-dependent protein kinase nor calcium/phospholipid-dependent protein kinase appear to have modulatory effects on electromotility. Dibutyryl cGMP (DBcGMP), in concentrations of 200 μM, elicited a significant electromotility magnitude increase. The DBcGMP effect could be inhibited by co-application of 200 μM DBcGMP and 100 μM 8-Rp-pCPT-cGMPS (8-4-chlorophenylthio-guanosine 3',5'- cyclic monophosphothioate, Rp isomer, a cGMP antagonist). Our results suggest that OHC electromotility is modulated by a cGMP-dependent pathway.

Original languageEnglish
Pages (from-to)29-42
Number of pages14
JournalHearing Research
Volume137
Issue number1-2
DOIs
StatePublished - Nov 1999
Externally publishedYes

Fingerprint

Outer Auditory Hair Cells
Cyclic GMP
Dimethyl Sulfoxide
Colforsin
Protein Kinase C
Dibutyryl Cyclic GMP
Guanosine
Cyclic AMP-Dependent Protein Kinases
Adenylyl Cyclases
Electric Stimulation
Cell Movement
Guinea Pigs
Acetates
Phosphorylation
Membranes

All Science Journal Classification (ASJC) codes

  • Sensory Systems

Cite this

Szönyi, M., He, D. Z., Ribári, O., Sziklai, I., & Dallos, P. (1999). Cyclic GMP and outer hair cell electromotility. Hearing Research, 137(1-2), 29-42. https://doi.org/10.1016/S0378-5955(99)00127-6

Cyclic GMP and outer hair cell electromotility. / Szönyi, Magdolna; He, David Z.; Ribári, Ottó; Sziklai, István; Dallos, Peter.

In: Hearing Research, Vol. 137, No. 1-2, 11.1999, p. 29-42.

Research output: Contribution to journalArticle

Szönyi, M, He, DZ, Ribári, O, Sziklai, I & Dallos, P 1999, 'Cyclic GMP and outer hair cell electromotility', Hearing Research, vol. 137, no. 1-2, pp. 29-42. https://doi.org/10.1016/S0378-5955(99)00127-6
Szönyi, Magdolna ; He, David Z. ; Ribári, Ottó ; Sziklai, István ; Dallos, Peter. / Cyclic GMP and outer hair cell electromotility. In: Hearing Research. 1999 ; Vol. 137, No. 1-2. pp. 29-42.
@article{6fd3ee5a2b9f4a618effd0ea3377fef6,
title = "Cyclic GMP and outer hair cell electromotility",
abstract = "The aim of this study is to examine the effect of phosphorylation pathways on the electrically evoked fast motile response of isolated outer hair cells (OHCs). Transcellular electrical stimulation was applied in the microchamber to guinea pig OHCs and motility was measured before and after drug application. Forskolin (adenylate cyclase activator), phorbol 12- myristate 13-acetate (PMA, protein kinase C activator) and dibutyryl 3',5'- cyclic guanosine monophosphate (cGMP agonist) were studied. As controls, L15 medium and dimethyl-sulfoxide (DMSO) were used. In each group, 12 cells were measured. Forskolin and PMA were dissolved in 0.1{\%} DMSO to render them membrane permeable. DMSO by itself caused a statistically significant electromotility magnitude decrease. Forskolin and PMA could not reverse the motility decrease due to DMSO, the effects seen in their presence were the same as observed with DMSO alone. Thus, neither 3',5'-cyclic AMP-dependent protein kinase nor calcium/phospholipid-dependent protein kinase appear to have modulatory effects on electromotility. Dibutyryl cGMP (DBcGMP), in concentrations of 200 μM, elicited a significant electromotility magnitude increase. The DBcGMP effect could be inhibited by co-application of 200 μM DBcGMP and 100 μM 8-Rp-pCPT-cGMPS (8-4-chlorophenylthio-guanosine 3',5'- cyclic monophosphothioate, Rp isomer, a cGMP antagonist). Our results suggest that OHC electromotility is modulated by a cGMP-dependent pathway.",
author = "Magdolna Sz{\"o}nyi and He, {David Z.} and Ott{\'o} Rib{\'a}ri and Istv{\'a}n Sziklai and Peter Dallos",
year = "1999",
month = "11",
doi = "10.1016/S0378-5955(99)00127-6",
language = "English",
volume = "137",
pages = "29--42",
journal = "Hearing Research",
issn = "0378-5955",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Cyclic GMP and outer hair cell electromotility

AU - Szönyi, Magdolna

AU - He, David Z.

AU - Ribári, Ottó

AU - Sziklai, István

AU - Dallos, Peter

PY - 1999/11

Y1 - 1999/11

N2 - The aim of this study is to examine the effect of phosphorylation pathways on the electrically evoked fast motile response of isolated outer hair cells (OHCs). Transcellular electrical stimulation was applied in the microchamber to guinea pig OHCs and motility was measured before and after drug application. Forskolin (adenylate cyclase activator), phorbol 12- myristate 13-acetate (PMA, protein kinase C activator) and dibutyryl 3',5'- cyclic guanosine monophosphate (cGMP agonist) were studied. As controls, L15 medium and dimethyl-sulfoxide (DMSO) were used. In each group, 12 cells were measured. Forskolin and PMA were dissolved in 0.1% DMSO to render them membrane permeable. DMSO by itself caused a statistically significant electromotility magnitude decrease. Forskolin and PMA could not reverse the motility decrease due to DMSO, the effects seen in their presence were the same as observed with DMSO alone. Thus, neither 3',5'-cyclic AMP-dependent protein kinase nor calcium/phospholipid-dependent protein kinase appear to have modulatory effects on electromotility. Dibutyryl cGMP (DBcGMP), in concentrations of 200 μM, elicited a significant electromotility magnitude increase. The DBcGMP effect could be inhibited by co-application of 200 μM DBcGMP and 100 μM 8-Rp-pCPT-cGMPS (8-4-chlorophenylthio-guanosine 3',5'- cyclic monophosphothioate, Rp isomer, a cGMP antagonist). Our results suggest that OHC electromotility is modulated by a cGMP-dependent pathway.

AB - The aim of this study is to examine the effect of phosphorylation pathways on the electrically evoked fast motile response of isolated outer hair cells (OHCs). Transcellular electrical stimulation was applied in the microchamber to guinea pig OHCs and motility was measured before and after drug application. Forskolin (adenylate cyclase activator), phorbol 12- myristate 13-acetate (PMA, protein kinase C activator) and dibutyryl 3',5'- cyclic guanosine monophosphate (cGMP agonist) were studied. As controls, L15 medium and dimethyl-sulfoxide (DMSO) were used. In each group, 12 cells were measured. Forskolin and PMA were dissolved in 0.1% DMSO to render them membrane permeable. DMSO by itself caused a statistically significant electromotility magnitude decrease. Forskolin and PMA could not reverse the motility decrease due to DMSO, the effects seen in their presence were the same as observed with DMSO alone. Thus, neither 3',5'-cyclic AMP-dependent protein kinase nor calcium/phospholipid-dependent protein kinase appear to have modulatory effects on electromotility. Dibutyryl cGMP (DBcGMP), in concentrations of 200 μM, elicited a significant electromotility magnitude increase. The DBcGMP effect could be inhibited by co-application of 200 μM DBcGMP and 100 μM 8-Rp-pCPT-cGMPS (8-4-chlorophenylthio-guanosine 3',5'- cyclic monophosphothioate, Rp isomer, a cGMP antagonist). Our results suggest that OHC electromotility is modulated by a cGMP-dependent pathway.

UR - http://www.scopus.com/inward/record.url?scp=0345425778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345425778&partnerID=8YFLogxK

U2 - 10.1016/S0378-5955(99)00127-6

DO - 10.1016/S0378-5955(99)00127-6

M3 - Article

VL - 137

SP - 29

EP - 42

JO - Hearing Research

JF - Hearing Research

SN - 0378-5955

IS - 1-2

ER -